Dexcom has integrated generative AI into its Stelo continuous glucose monitor, making it the first medical device company to do so. The AI platform analyzes data from the biosensor, meal logging, and other wearable technologies to provide personalized insights and recommendations for users. The AI capabilities are powered by Google Cloud’s AI models, enabling Dexcom to build a platform that can gather and analyze data from different sources. Dexcom believes that AI will play a transformative role in diabetes management and healthcare by providing a more personalized experience and improving health outcomes for users.
Source link
Dexcom Adds Generative AI Platform to Its Over-the-Counter CGM
